Kingdom

Kingdom is an innovative player in the Biotechnology, Food and Beverage, Life Sciences, and Manufacturing industries, founded in 2019 and headquartered in the United States. The company has developed a proprietary line of natural functional ingredients branded as Superculture®. These ingredients are a new class of clinically-validated postbiotics aimed at addressing unmet health needs in pets, claiming industry-leading efficacy and unlocking lucrative marketing opportunities for partner brands.

Currently, Kingdom has two pet-focused ingredients in the market: Superculture® Pet Oral and Superculture® Pet Immune, with its first human ingredient under development. By the end of 2025, the company aims to have completed 10 clinical studies to substantiate its claims. Notably, it is flanked by partnerships with leading pet brands, indicating strong market penetration and growth potential.

Kingdom secured a substantial $25.00M in a Series A investment on October 5, 2021, backed by notable investors including Shine Capital, Tet Ventures, Lux Capital, Pioneer Fund, Valor Equity Partners, Tao Capital Partners, Digitalis Ventures, Salt Creek Capital, Reference Capital SA, and Jay Zaveri.